189 related articles for article (PubMed ID: 9098463)
1. Evaluation of body composition during low-dose estrogen oral contraceptives treatment.
Franchini M; Caruso C; Nigrelli S; Poggiali C
Acta Eur Fertil; 1995; 26(2):69-73. PubMed ID: 9098463
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
5. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
6. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
Endrikat J; Gerlinger C; Cronin M; Wessel J; Ruebig A; Rosenbaum P; Düsterberg B
Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649
[TBL] [Abstract][Full Text] [Related]
7. Effects of two different oral contraceptives on total body water: a randomized study.
Machado RB; Tachotti F; Cavenague G; Maia E
Contraception; 2006 Apr; 73(4):344-7. PubMed ID: 16531163
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Coenen CM; Thomas CM; Borm GF; Rolland R
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
[TBL] [Abstract][Full Text] [Related]
9. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women.
Reubinoff BE; Grubstein A; Meirow D; Berry E; Schenker JG; Brzezinski A
Fertil Steril; 1995 Mar; 63(3):516-21. PubMed ID: 7851580
[TBL] [Abstract][Full Text] [Related]
11. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
Gross U; Honcamp M; Daume E; Frank M; Düsterberg B; Doss MO
Horm Metab Res; 1995 Aug; 27(8):379-83. PubMed ID: 7590628
[TBL] [Abstract][Full Text] [Related]
12. A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet (gestodene75/EE20) on body fat.
de Melo NR; Aldrighi JM; Faggion D; Reyes VR; Souza JB; Fernandes CE; Larson E
Contraception; 2004 Jul; 70(1):65-71. PubMed ID: 15208055
[TBL] [Abstract][Full Text] [Related]
13. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
Norris LA; Bonnar J
Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
[TBL] [Abstract][Full Text] [Related]
14. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
[TBL] [Abstract][Full Text] [Related]
15. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
16. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of ovarian function using a triphasic combination with gestodene].
Rozenbaum H
Rev Fr Gynecol Obstet; 1988 Jun; 83(6):449-52. PubMed ID: 3406638
[TBL] [Abstract][Full Text] [Related]
18. [Influence of the very low dose oral contraception on the blood presure, body weight and general condition of the patients].
Nikolov A
Akush Ginekol (Sofiia); 2009; 48(4):11-6. PubMed ID: 20198780
[TBL] [Abstract][Full Text] [Related]
19. [Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].
Negri P; D'Errico G; Minisci N; Tomasi A
Minerva Ginecol; 1988 Dec; 40(12):699-707. PubMed ID: 2977429
[TBL] [Abstract][Full Text] [Related]
20. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
Spellacy WN; Birk SA; Buggie J; Buhi WC
J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
